Patents
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
07/1997
07/09/1997CN1154067A Use of a progesterone antagonist and of a gestagen for the treatment of endometriosis or leiomyomata uteri
07/09/1997CN1153784A Biotin derivatives
07/08/1997US5646158 For treating allergic and inflammatory diseases and for inhibiting the production of tumor necrosis factor
07/08/1997US5646152 Treating psychological disorders with corticotropin releasing factor antagonists
07/08/1997US5646144 For treating disorders in which substance p plays a part in development
07/08/1997US5646138 Prevention of inflammatory or allergic reactions, treatment of cardiovascular or haemodynamic disorders
07/08/1997US5645852 Butyric ester cyto-differtiating agents
07/03/1997WO1997023625A1 Integrin-linked kinase, its inhibitors and methods of medical treatment using these inhibitors, gene therapy and pseudo-substrate inhibitors
07/03/1997WO1997023613A2 Cell activation process and reagents therefor
07/03/1997WO1997023465A1 New barbituric acid derivatives, processes for their production and pharmaceutical agents containing these compounds
07/03/1997WO1997023461A1 Tri-substituted phenyl derivatives useful as pde iv inhibitors
07/03/1997WO1997023460A1 Tri-substituted phenyl derivatives useful as pde iv inhibitors
07/03/1997WO1997023457A1 Imides as pde iii, pde iv and tnf inhibitors
07/03/1997WO1997023453A1 17-side chain alkynyl-and 20-oxopregna-derivatives of vitamin d, methods for their production and pharmaceutical compositions thereof
07/03/1997WO1997023240A2 Conjugate comprising an active agent, a polypeptide and a polyether
07/03/1997WO1997023230A1 Method of treating disorders characterized by overexpression of cytidine deaminase or deoxycytidine deaminase
07/03/1997WO1997023206A1 Drug delivery device
07/03/1997WO1997023205A1 Transdermal device for the delivery of flurbiprofen
07/03/1997WO1997016185A3 A pharmaceutical composition for the treatment of autoimmune diseases
07/03/1997CA2241688A1 Imides as pde iii, pde iv and tnf inhibitors
07/03/1997CA2241255A1 Method of treating disorders characterized by overexpression of cytidine deaminase or deoxycytidine deaminase
07/03/1997CA2241011A1 17-side chain alkynyl-and 20-oxopregna-derivatives of vitamin d, methods for their production and pharmaceutical compositions thereof
07/03/1997CA2240349A1 Drug delivery device
07/03/1997CA2238873A1 Cell activation process and reagents therefor
07/03/1997CA2238400A1 Transdermal device for the delivery of flurbiprofen
07/02/1997EP0781776A2 Water soluble rapamycin esters
07/02/1997EP0781558A2 Pharmaceutical use of heparin cofactor II
07/02/1997EP0781556A1 Use of condensed dihydropyridines for the treatement of chronic inflammatory processes
07/02/1997EP0781550A1 Bioadhesive pharmaceutical composition for the controlled release of active agents
07/02/1997EP0781546A1 A multi-layered film preparation
07/02/1997EP0781340A1 Methods and compositions for identifying streptococcus containing a cysteine protease or fragment thereof
07/02/1997EP0781336A1 A human map kinase homolog
07/02/1997EP0781282A1 [1,2,4]TRIAZOLO[4,3-a]QUINOXALINONE DERIVATIVES, THEIR PREPARATION AND USE
07/02/1997EP0781277A1 Neurokinin antagonists
07/02/1997EP0781132A1 Methods of inhibiting ulcerative mucositis
07/02/1997EP0730588B1 Isoxazoline compounds as antiinflammatory agents
07/02/1997CN1153510A Amide derivs. and their therapeutic use
07/01/1997US5643964 Natural amino acid derivatives as metalloproteinase inhibitors
07/01/1997US5643946 Compounds useful for treating allergic and inflammatory diseases
07/01/1997US5643943 Systemic administration of esters and amides of antioxidants which may be used as antioxidant prodrug therapy for oxidative and inflammatory pathogenesis
07/01/1997US5643933 Substituted sulfonylphenylheterocycles as cyclooxygenase-2 and 5-lipoxygenase inhibitors
07/01/1997US5643932 Superoxide radical inhibitor
07/01/1997US5643899 Lipids for epidermal moisturization and repair of barrier function
07/01/1997US5643895 Phosphonoacetic esters and acids as anti-inflammatories
07/01/1997US5643893 Antiinflammatory agents or antiarthritic agents
07/01/1997US5643884 Antiinflammatory agents
07/01/1997US5643870 Topical asthma treatment
07/01/1997US5643598 Method of skin care utilizing liposomes containing Scutellaria extracts
07/01/1997CA2128248C Amino acids useful as inhibitors of the advanced glycosylation of proteins
06/1997
06/26/1997WO1997022698A2 Chemokine receptors 88-2b[ckr-3] and 88c and their antibodies
06/26/1997WO1997022619A2 INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME
06/26/1997WO1997022618A1 INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME
06/26/1997WO1997022613A1 Phospholipid derivatives of phosphono-carboxylic acids, the production of said derivatives and the use of said derivatives as antiviral medicaments
06/26/1997WO1997022604A1 Novel substituted 4-(1h-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic diseases
06/26/1997WO1997022587A1 Alpha-substituted arylsulphonamido hydroxamic acids as tnf-alpha and matrix metalloproteinase inhibitors
06/26/1997WO1997022347A1 Potentiation of complement and coagulation inhibitory properties of c1-inhibitor.
06/26/1997WO1997022340A1 Rapid release tablet comprising tolfenamic acid or a pharmaceutically acceptable salt thereof
06/26/1997DE19548624A1 Neue Barbitursäure-Derivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel New barbituric acid derivatives, processes for their preparation and medicaments containing these compounds
06/26/1997DE19548114A1 Konjugat, umfassend einen Wirkstoff, ein Polypeptid und einen Polyether A conjugate comprising an active substance, a polypeptide and a polyether
06/26/1997CA2244396A1 Rapid release tablet comprising tolfenamic acid or a pharmaceutically acceptable salt thereof
06/26/1997CA2240489A1 Inhibitors of interleukin-1.beta. converting enzyme
06/26/1997CA2240366A1 New phospholipid derivatives of phosphonocarboxylic acids, the production thereof as well as their use as antiviral pharmaceutical agents
06/25/1997EP0780386A1 Matrix metalloprotease inhibitors
06/25/1997EP0780369A1 1-Phenyl-2-dimethylaminomethyl-cyclohexan-1-ol derivatives as pharmaceutical agents
06/25/1997EP0780129A2 Adrenal cortical steroid containing external therapeutic composition for dermatitis
06/25/1997EP0780128A2 Crotonic acid amide derivatives and lipoprotein containing compositions
06/25/1997EP0779923A2 Interleukin-1 type 3 receptors
06/25/1997EP0779889A1 PYRAZOLO 3,4-g]QUINOXALINE COMPOUNDS WHICH INHIBIT PDGF RECEPTOR PROTEIN TYROSINE KINASE
06/25/1997EP0779888A1 Pyrimido [5,4-d]pyrimidines, drugs containing these compounds, their use, and process for preparing them
06/25/1997EP0779820A1 Bioadhesive-wound healing composition
06/25/1997EP0779816A1 Use of insulin-like growth factors (i) and (ii) for inhibition of inflammatory response
06/25/1997EP0696199A4 Amidino and guanidino substituted boronic acid inhibitors of trypsin-like enzymes
06/25/1997EP0636141B1 Pyrimidinyl acetamides as elastase inhibitors
06/25/1997CN1152915A Quinoline derivatives as leukotriene antagonists
06/25/1997CN1152871A Methods of use for peroxynitrite decompositionc atalysts, pharmaceutical compositions therefor
06/25/1997CN1152869A Treatment for atherosclerosis and other cardiovascular and inflammatory diseases
06/25/1997CN1152468A Slow releasing composition
06/25/1997CN1152434A Oral preparation of S(+)1,8-diethyl-1,3,4,9-tetrahydropyrano (3,4-b) indole-1-acetic acid
06/25/1997CN1035255C Heterotricyclic derivatives
06/24/1997US5641875 Dna construct encoding immunoglobulin g fc receptor comprising extracellular, transmembrane and cytoplasmic domains or functional portions thereof, which renders phagocytic cell comprising same
06/24/1997US5641863 Immunoglobulin g fc receptor comprising extracellular, transmembrane and cytoplasmic domains or functional portions thereof, which renders phagocytic cells comprising same
06/24/1997US5641800 Alleviate effect of septic shock, adult respiratory distress syndrome, pancreatitis, trauma, bronchial asthma, allergic rhinitis, and rheumatoid arthritis
06/24/1997US5641786 Quinuclidine derivatives
06/24/1997US5641777 Neurokinin receptor antagonist
06/24/1997US5641776 Treating rheumatoid diseases
06/24/1997US5641669 Platelet-activating factor acetylhydrolase
06/24/1997US5641657 DNA encoding an interleukin-6 splice variant
06/24/1997US5641497 Gastrointestinal defensins, cDNA sequences and method for the production and use thereof
06/19/1997WO1997021725A1 3-aminoethyl-n-amidino-2,5-dihydropyrrole derivatives having arginine mimetic properties
06/19/1997WO1997021724A1 Steroid nitrite ester derivatives useful as anti-inflammatory drugs
06/19/1997WO1997021721A1 Novel steroid nitrite/nitrate ester derivatives useful as anti-inflammatory drugs
06/19/1997WO1997021716A1 NAPHTHYL GLYOXAMIDES AS sPLA2 INHIBITORS
06/19/1997WO1997021710A1 Use of heteroaromatic and tricyclic 1,4-dihydro-1,4-dioxo-naphthalene derivatives, resulting novel compounds and therapeutical use thereof
06/19/1997WO1997021709A1 Use of mono- or diketone tetracyclic derivatives, resulting novel compounds and therapeutical use thereof
06/19/1997WO1997021702A1 3-benzylaminopyrrolidines and -piperidines as tachykinin receptor antagonists
06/19/1997WO1997021690A1 D-amino acid derived inhibitors of cysteine and serine proteases
06/19/1997WO1997021676A1 Azetidinone compounds for the treatment of atherosclerosis
06/19/1997WO1997021675A1 Monocyclic beta-lactame derivatives for treatment of atherosclerosis
06/19/1997WO1997021668A1 Phenylacetamide derivatives
06/19/1997WO1997021664A1 NAPHTHYL ACETAMIDES AS sPLA2 INHIBITORS